Skip to main content
Funded Studies

Manolo Carta, PhD

Researcher at Department of Biomedical Science, University of Cagliari

Location: Cagliari Italy

/* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman","serif";}

Manolo Carta, PhD, graduated from the University of Cagliari (Italy) in 2000 with a degree in biology. From the same institution he obtained a PhD in human nutrition (2004), studying the effect of nutrients deprivation on motor and mnemonic functions. In early 2005 Dr. Carta joined Professor Anders Björklund´s group at Lund University, first as a postdoctoral fellow and more recently as assistant professor. Since then, he has focused his interests on Parkinson's disease and understanding the mechanisms underlying the appearance of levodopa-induced dyskinesia. Dr. Carta's recent work on the role of the serotonin system in dyskinesia has identified a possible new therapeutic target for the management of levodopa-induced dyskinesia.

In late 2010, Dr. Carta obtained a permanent research position at the University of Cagliari, where he established his own research group. His research has been supported by The Michael J. Fox Foundation, the Parkinson Disease Foundation, the Swedish Parkinson Foundation and the Italian Ministry of University and Research. 

Associated Grants

  • Pregnenolone for the Treatment of L-DOPA-induced Dyskinesia in Parkinson's disease


  • 5-alpha-reductase Inhibition for the Treatment of Levodopa-induced Dyskinesia


  • 5-Hydroxytryptophan and Eltoprazine for the Treatment of Levodopa-Induced Dyskinesia


  • Pharmacological Targeting of the 5-HT1, A2A and NMDA Receptors: An Integrative Approach to Dyskinesia


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.